POLR1B and schizophrenia: PET studies have demonstrated that compared to healthy controls, antipsychotic-free patients with schizophrenia showed reduced hippocampal binding of an α5-GABAA selective ligand [82], but along with CHR-P individuals [83], show no differences with less specific α1-3,5-GABAA ligands [84–87].